The more-transmissible Delta coronavirus variant is believed to be significantly more widespread than the current federal projections, according to two senior Biden administration health officials with knowledge of the situation.
With the global supply of Covid-19 vaccine still woefully inadequate, vaccine makers are scouring the pharmaceutical landscape for partners to ramp up manufacturing, and civil society groups are pressing politicians to waive intellectual property protections in a bid to spur still more production.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NI4SKHSLKFMSVK72QV5TZFDQTU.jpg)
